MFS‐LE showed no clear difference in bronchopulmonary dysplasia/chronic lung disease compared with S‐LE (low certainty).
It is very uncertain whether MS‐LE changes bronchopulmonary dysplasia/chronic lung disease compared with S‐LE (very low certainty).
All fish oil containing LE showed no clear difference in bronchopulmonary dysplasia/chronic lung disease compared with S‐LE (low certainty).
It is very uncertain whether all alternative LE changes bronchopulmonary dysplasia/chronic lung disease compared with S‐LE (very low certainty).
MOFS‐LE showed no clear difference in bronchopulmonary dysplasia/chronic lung disease compared with S‐LE (low certainty).
OS‐LE showed no clear difference in bronchopulmonary dysplasia/chronic lung disease (sensitivity analysis) compared with S‐LE (low certainty).
It is very uncertain whether OS‐LE changes bronchopulmonary dysplasia/chronic lung disease (incidence ‐… compared with S‐LE (very low certainty).
It is very uncertain whether high‐dose changes bronchopulmonary dysplasia/chronic lung disease (BPD) at 36 weeks'… compared with standard‐dose strategies (very low certainty).
It is very uncertain whether high‐dose changes bronchopulmonary dysplasia/chronic lung disease (BPD) at 36 weeks'… compared with standard‐dose strategies (very low certainty).
Caffeine showed no clear difference in bronchopulmonary dysplasia/chronic lung disease: defined as 28 days… compared with other methylxanthines (low certainty).